<VariationArchive RecordType="classified" VariationID="996746" VariationName="NM_001292034.3(TAB2):c.1398dup (p.Thr467fs)" VariationType="Duplication" Accession="VCV000996746" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-26" DateCreated="2021-02-20" MostRecentSubmission="2021-04-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="984463" VariationID="996746">
      <GeneList>
        <Gene Symbol="LOC126859827" FullName="BRD4-independent group 4 enhancer GRCh37_chr6:149699707-149700906" GeneID="126859827" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="149378571" stop="149379770" display_start="149378571" display_stop="149379770" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="TAB2" FullName="TGF-beta activated kinase 1 (MAP3K7) binding protein 2" GeneID="23118" HGNC_ID="HGNC:17075" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="149217926" stop="149411607" display_start="149217926" display_stop="149411607" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="149639435" stop="149732746" display_start="149639435" display_stop="149732746" Strand="+" />
          </Location>
          <OMIM>605101</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TAB2">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TAB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001292034.3(TAB2):c.1398dup (p.Thr467fs)</Name>
      <CanonicalSPDI>NC_000006.12:149379311:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="149379311" stop="149379312" display_start="149379311" display_stop="149379312" variantLength="1" positionVCF="149379311" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="149700447" stop="149700448" display_start="149700447" display_stop="149700448" variantLength="1" positionVCF="149700447" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>T435fs</ProteinChange>
      <ProteinChange>T467fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.149700449dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.149700449dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.149379313dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.149379313dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021386.2" sequenceAccession="NG_021386" sequenceVersion="2" change="g.166390dup">
            <Expression>NG_021386.2:g.166390dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001292034.3" sequenceAccession="NM_001292034" sequenceVersion="3" change="c.1398dup" MANESelect="true">
            <Expression>NM_001292034.3:c.1398dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001278963.1" sequenceAccession="NP_001278963" sequenceVersion="1" change="p.Thr467fs">
            <Expression>NP_001278963.1:p.Thr467fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001292035.3" sequenceAccession="NM_001292035" sequenceVersion="3" change="c.1302dup">
            <Expression>NM_001292035.3:c.1302dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001278964.1" sequenceAccession="NP_001278964" sequenceVersion="1" change="p.Thr435fs">
            <Expression>NP_001278964.1:p.Thr435fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369506.1" sequenceAccession="NM_001369506" sequenceVersion="1" change="c.1398dup">
            <Expression>NM_001369506.1:c.1398dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356435.1" sequenceAccession="NP_001356435" sequenceVersion="1" change="p.Thr467fs">
            <Expression>NP_001356435.1:p.Thr467fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015093.6" sequenceAccession="NM_015093" sequenceVersion="6" change="c.1398dup">
            <Expression>NM_015093.6:c.1398dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055908.1" sequenceAccession="NP_055908" sequenceVersion="1" change="p.Thr467fs">
            <Expression>NP_055908.1:p.Thr467fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="605101.0005" DB="OMIM" />
        <XRef Type="rs" ID="1781524947" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
        <XRef ID="0347" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001292034.3(TAB2):c.1398dup (p.Thr467fs) AND Congenital heart defects, multiple types, 2" Accession="RCV001291526" Version="2">
        <ClassifiedConditionList TraitSetID="9089">
          <ClassifiedCondition DB="MedGen" ID="C3554279">Congenital heart defects, multiple types, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-02-20" MostRecentSubmission="2021-04-13">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28386937</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31250519</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9089" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17513" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital heart defects, multiple types, 2</ElementValue>
                <XRef ID="MONDO:0014000" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital heart defects, nonsyndromic, 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHTD2</ElementValue>
                <XRef Type="MIM" ID="614980" DB="OMIM" />
              </Symbol>
              <XRef ID="C3554279" DB="MedGen" />
              <XRef ID="MONDO:0014000" DB="MONDO" />
              <XRef Type="MIM" ID="614980" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2917011" SubmissionDate="2021-02-16" DateLastUpdated="2021-02-20" DateCreated="2021-02-20">
        <ClinVarSubmissionID localKey="SUB8971763" submittedAssembly="GRCh37" title="SUB8971763" />
        <ClinVarAccession Accession="SCV001478262" DateUpdated="2021-02-20" DateCreated="2021-02-20" Type="SCV" Version="1" SubmitterName="Division of Biology and Genetics, University of Brescia" OrgID="507568" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31250519</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
              <FamilyData NumFamiliesWithVariant="2" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TAB2">
              <Name>TGF-beta activated kinase 1 (MAP3K7) binding protein 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_015093.5:exon 5</GeneLocation>
          </Location>
          <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
            <XRef DB="Variation Ontology" ID="0347" URL="http://purl.obolibrary.org/obo/VariO_0347" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015093.5:c.1398dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614980" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28386937</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB8971763</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3048746" SubmissionDate="2021-04-02" DateLastUpdated="2021-04-13" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="605101.0005_CONGENITAL HEART DISEASE, MULTIPLE TYPES, 2" title="TAB2, 1-BP DUP, NT1398_CONGENITAL HEART DISEASE, MULTIPLE TYPES, 2" />
        <ClinVarAccession Accession="SCV001548360" DateUpdated="2021-04-13" DateCreated="2021-04-13" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a sister (patient 1) and brother (patient 3) and the brother's daughter (patient 2), who had polyvalvular heart disease as well as facial dysmorphism and features of connective tissue disease (CHTD2; 614980), Ritelli et al. (2018) identified heterozygosity for a 1-bp duplication (c.1398dup, NM_015093.5) in the TAB2 gene, causing a frameshift predicted to result in a premature termination codon (Thr467TyrfsTer6) with loss of 222 amino acids, including the zinc finger domain.</Attribute>
              <Citation>
                <ID Source="PubMed">28386937</ID>
              </Citation>
              <XRef DB="OMIM" ID="614980" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Variant Function</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Morlino et al. (2019) studied the functional consequences of the c.1398dup variant, located in exon 4 of the TAB2 gene. Quantitative PCR of skin fibroblasts from patient 1 of Ritelli et al. (2018) showed reduced TAB2 transcription levels compared to control cells, with partial recovery of mutant TAB2 mRNA levels after cyclohexamide treatment, indicating that endogenous mutant TAB2 transcripts undergo nonsense-mediated decay. These results were confirmed by direct sequencing of RT-PCR products of total RNA derived from patient and control fibroblasts. Immunoblot analysis of transfected HEK293 cells showed that cells carrying the mutant expressed an approximately 50-kb aberrant protein, and a truncated TAB2 protein was consistently detected in patient cell lysates. Coimmunoprecipitation assays in transfected HEK293 cells revealed that the mutant impairs formation of the TAK1 (MAP3K7; 602614)/TAB2 complex. Western blot of skin fibroblasts from patients 1 and 2 showed reduced TAK1 levels, as well as reduced levels of TAK1 autophosphorylation, compared to controls; in addition, downstream signaling pathways showed alterations. Compared to wildtype cells, both patients' fibroblasts cycled less actively and were significantly enriched in G0/G1 phases. Analysis of expression profiles of genes involved in various components of the extracellular matrix (ECM) and collagen biogenesis showed global dysregulation. Immunofluorescence staining of patient fibroblasts showed disarray of both type 3 (COL3A1; 120180) and type 5 (see COL5A1, 120215) collagen ECMs, and fibronectin (FN1; 135600) was strongly reduced in patient cells.</Attribute>
              <Citation>
                <ID Source="PubMed">31250519</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">28386937</ID>
              </Citation>
              <XRef DB="OMIM" ID="602614" Type="MIM" />
              <XRef DB="OMIM" ID="120180" Type="MIM" />
              <XRef DB="OMIM" ID="120215" Type="MIM" />
              <XRef DB="OMIM" ID="135600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TAB2" />
          </GeneList>
          <Name>TAB2, 1-BP DUP, NT1398</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, NT1398</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605101.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CONGENITAL HEART DISEASE, MULTIPLE TYPES, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2917011" TraitType="Disease" MappingType="XRef" MappingValue="614980" MappingRef="OMIM">
        <MedGen CUI="C3554279" Name="Congenital heart defects, multiple types, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3048746" TraitType="Disease" MappingType="Name" MappingValue="CONGENITAL HEART DISEASE, MULTIPLE TYPES, 2" MappingRef="Preferred">
        <MedGen CUI="C3554279" Name="Congenital heart defects, multiple types, 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

